• High-sensitivity cardiac troponin
    • overcomes early “troponin blind” period
    • allows rapid rule-in, rule-out protocols → impacts ED workflow
    • most will be + within 6 hrs
  • ‎single sample r/o only if patient’s last had CP > 6 hrs ago
  • ‎Risk scores
  • ⚠️ late presentation MI with low hs-cTn may have a small delta for troponin change

Troponin Elevation

flowchart TD
    A[Elevated Troponin] --> B{Rise and/or fall}
    A --> C[Flat/No change]
    C --> D(Chronic<br>Structural ♥ dz, CKD, etc.)
    B --> |Acute Ischemia| E[Acute MI]
    B --> |≠ acute Ischemia| F[Myocardial injury]
  • Elevated troponin

    • no CC/MCC
    • non cardiac rise in troponin, e.g. rhabdomyolysis, sepsis, etc.
  • Type 2 NSTEMI

    • MCC
    • Elevated troponin that is probably cardiac-related, but not due to primary plaque rupture, i.e. someone with underlying CAD who presents with Hypertensive Crisis, sepsis, HF exacerbation, severe anemia, etc.
  • Type 1 NSTEMI

    • MCC
    • Plaque rupture, needs a stent or has documented severe lesions, or has echo WMA
    • This counts as an MCC and also outcomes are reportable.
    • Activates NSTEMI care pathway for accreditation → echo within 30 days, cardiac rehab, etc.
  • Demand ischemia

    • CC
    • Not an MI. Use this in a patient with ECG changes or chest pain, but without troponin elevation.
  • Don’t call everything an “NSTEMI”:

    • A lot of type 2 NSTEMI patients are really sick from non-cardiac illnesses and if they die or get readmitted then incorrectly makes outcomes look worse.